ArticleInternational journal of surgery case reports2026
Langerhans cell histiocytosis presenting as a cecal mass in an adolescent: a rare surgical case report.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Langerhans cell histiocytosis (LCH) is a rare, idiopathic, multifocal disease that commonly occurs in the skin and skeletal system, although involvement of the gastrointestinal tract is exceptional. Only a limited number of cases have been reported in the literature, particularly at the intestinal level, often with incidental diagnosis after colonoscopic polypectomy, and presentation as a cecal mass is extremely uncommon. Case presentation: A 15-year-old boy presented with abdominal pain and a non-tender right iliac fossa mass. Hematological and biochemical tests were within normal limits. Initial imaging studies, including ultrasound and contrast-enhanced computed tomography, revealed a cecal mass associated with mesenteric lymphadenopathy, with radiological features suggestive of lymphoma. Because of intolerance to bowel preparation, colonoscopy could not be performed. In addition to a history of treated intermittent distension with vomiting, which raised concern for recurrent sub-acute intestinal obstruction, a laparoscopy-assisted surgical approach was therefore chosen. Intraoperatively, a cecal mass with multiple focal swellings of the mesocolon was identified. A right hemicolectomy with ileo-transverse anastomosis was performed according to oncological principles. Post-operative PET imaging showed no evidence of residual disease, and the patient was subsequently enrolled in a follow-up program. This case highlights the rarity of intestinal LCH and the importance of considering it in the differential diagnosis of abdominal masses in pediatric patients. Radiological imaging studies have shown neither residual disease nor recurrence during 9 months of regular follow-up. Clinical discussion: The World Health Organization classifies LCH within the hematopoietic and lymphoid tumors placing it on a spectrum between benign and malignant behavior depending on other factors, with unifocal or multifocal lesions and single- or multisystem involvement, which likely predict prognosis and guide post-surgical treatment. Conclusion: The rarity of intestinal LCH presenting as a cecal mass highlights the importance of considering it in the differential diagnosis of abdominal masses in pediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.